Literature DB >> 12565870

VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice.

Atsushi Kiba1, Hiroshi Sagara, Takeshi Hara, Masabumi Shibuya.   

Abstract

VEGF family members play important roles in angiogenesis and vascular permeability. VEGF-A-transgenic mice showed an increased vascularization with edema due to hyper-vascular permeability and subcutaneous hemorrhage as side effects. VEGF-A binds and activates two receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1). To dissect the signals of these two receptors, we generated transgenic mice overexpressing either the VEGFR-2-specific ligand VEGF-E(NZ-7) or VEGFR-1-specific ligand PlGF-II under the control of the Keratin-14 promoter. VEGF-E-mice showed a significant increase in vascularization (about 10-fold compared to control mice) in subcutaneous tissues, whereas PlGF-mice showed only a 2-3-fold increase. Interestingly, VEGF-E-mice did not show any clear edematous lesions or hemorrhagic spots on the skin. Microscopically, VEGF-E-induced capillary networks have a well organized structure with the recruitment of pericytes. These results indicate that VEGF-E is a new angiogenic agent with less side effects for clinical usage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12565870     DOI: 10.1016/s0006-291x(02)03033-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  Gene and protein therapies utilizing VEGF for ALS.

Authors:  Orion P Keifer; Deirdre M O'Connor; Nicholas M Boulis
Journal:  Pharmacol Ther       Date:  2013-10-29       Impact factor: 12.310

2.  Selective stimulation of VEGFR2 accelerates progressive renal disease.

Authors:  Waichi Sato; Katsuyuki Tanabe; Tomoki Kosugi; Kelly Hudkins; Miguel A Lanaspa; Li Zhang; Martha Campbell-Thompson; Qiuhong Li; David A Long; Charles E Alpers; Takahiko Nakagawa
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

3.  Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy.

Authors:  N Miyamoto; Y de Kozak; J C Jeanny; A Glotin; F Mascarelli; P Massin; D BenEzra; F Behar-Cohen
Journal:  Diabetologia       Date:  2006-12-23       Impact factor: 10.122

4.  Tyrosine Kinase Receptor Flt/VEGFR Family: Its Characterization Related to Angiogenesis and Cancer.

Authors:  Masabumi Shibuya
Journal:  Genes Cancer       Date:  2010-11

5.  Pre-B cell colony enhancing factor (PBEF/NAMPT/Visfatin) and vascular endothelial growth factor (VEGF) cooperate to increase the permeability of the human placental amnion.

Authors:  J M Astern; A C Collier; C E Kendal-Wright
Journal:  Placenta       Date:  2012-11-12       Impact factor: 3.481

6.  Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies.

Authors:  Masabumi Shibuya
Journal:  Genes Cancer       Date:  2011-12

Review 7.  VEGF-B: a survival, or an angiogenic factor?

Authors:  Xuri Li; Chunsik Lee; Zhongshu Tang; Fan Zhang; Pachiappan Arjunan; Yang Li; Xu Hou; Anil Kumar; Lijin Dong
Journal:  Cell Adh Migr       Date:  2009-10-03       Impact factor: 3.405

Review 8.  VEGFR and type-V RTK activation and signaling.

Authors:  Masabumi Shibuya
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

9.  Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation.

Authors:  Reto Huggenberger; Stefan Ullmann; Steven T Proulx; Bronislaw Pytowski; Kari Alitalo; Michael Detmar
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

Review 10.  Angiogenesis in cancer.

Authors:  Naoyo Nishida; Hirohisa Yano; Takashi Nishida; Toshiharu Kamura; Masamichi Kojiro
Journal:  Vasc Health Risk Manag       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.